Elutia Inc (NAS:ELUT)
$ 3.94 -0.21 (-5.06%) Market Cap: 136.18 Mil Enterprise Value: 133.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Elutia Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 12:00PM GMT
Release Date Price: $1.28 (+2.40%)
Ross Osborn
Cantor Fitzgerald, L.P. - Analyst

Good morning. My name is Ross Osborn, and I'm the medtech life science tools and diagnostics analyst at Cantor. And today, we have Aziyo Biologics with the Chairman and Chief Executive Officer -- President and CEO, Dr. Randy Mills; and Dr. Lishan Aklog, the Chairman and CEO of PAVmed, Lucid. Just starting off with you both just to provide a brief background on yourselves.

Randy Mills
Elutia Inc. - President & CEO

Randy Mills, been in the regenerative medicine space now for way too long and was actually one of the founders of the company that we called Aziyo Biologics, but we changed the name of that company recently. We'll be talking about a little bit more about that in a minute, to the company as it exists today, Elutia.

And at Elutia, we believe sort of fundamentally that if an implantable device could be made out of a biomaterial that overtime regenerates into the patient's own healthy tissue instead of staying there as a synthetic, that's something that a physician is going to pick, and a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot